Bausch Health Companies (BHC) FCF Payout Ratio Growth (1y) (2010 - 2013)
Bausch Health Companies (BHC) FCF Payout Ratio Growth (1y) (2010 - 2013) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -14.68% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -49.97% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -49.30% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -100.00% |
| Dec 31, 2012 | 158.22% |
| Dec 31, 2011 | 99.44% |
| Sep 30, 2011 | 26.74% |
| Dec 31, 2010 | -25,345.73% |
| Sep 30, 2010 | -15.17% |
| Jun 30, 2010 | -78.20% |